A new formulation containing calixarene molecules as an emergency treatment of uranium skin contamination

Health Physics

Volumn 99, Issue 3, 2010, Pages 430-434

  Spagnul, Aurélie ^a,b   Bouvier Capely, Céline ^a   Phan, Guillaume ^a   Rebière, François ^a   Fattal, Elias ^b  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

^b UNIV PARIS SUD   (France)

Author keywords

contamination; decontamination; skin dose; uranium

Indexed keywords

CALIXARENE; CHELATING AGENT; NANOCAPSULE; OIL; URANIUM; URANYL NITRATE; WATER; EMULSION;

ANIMAL; CHEMISTRY; CONFERENCE PAPER; DIFFUSION; DRUG EFFECT; EAR; EMERGENCY TREATMENT; EMULSION; INJURY; INTRADERMAL DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; RADIATION INJURY; SKIN; SWINE; TIME; WASTE MANAGEMENT; MEDICINAL CHEMISTRY; PROCEDURES; RADIATION INJURIES, EXPERIMENTAL; SURGERY; TOXICITY;

ADMINISTRATION, CUTANEOUS; ANIMALS; CALIXARENES; CHELATING AGENTS; CHEMISTRY, PHARMACEUTICAL; DECONTAMINATION; DIFFUSION; EAR; EMERGENCY TREATMENT; EMULSIONS; NANOCAPSULES; OILS; RADIATION INJURIES, EXPERIMENTAL; SKIN; SWINE; TIME FACTORS; URANIUM; URANYL NITRATE; WATER;

SUIDAE;

EID: 77955644925     PISSN: 00179078     EISSN: None     Source Type: Journal    
DOI: 10.1097/HP.0b013e3181d1a1b6     Document Type: Conference Paper

References (19)

1. ASN (French Nuclear Safety Authority). Guide national: Intervention médicale en cas dévènement nucléaire ou radiologique. Paris: ASN; V3.6; 2008 (in French). Available at: http://www.asn.fr/index.php/S-informer/Actualites/2008/ Version-2008-du-guide- Intervention-medicale-en-cas-d -evenement-nucleaire. Accessed 8 July 2010.
2. Baglan N, Cossonnet C, Trompier F, Ritt J, Berard P. Implementation of ICP-MS protocols for uranium urinary measurements in worker monitoring. Health Phys 77:455- 461; 1999.
3. Bailey BR, Eckerman KF, Townsend LW. An analysis of a puncture wound case with medical intervention. Radiat Protect Dosim 105:509 -512; 2003.
4. Boulet B. Extraction sélective des actinides par les calixarènes. Application a lanalyse radiotoxicologique. Paris: Université Paris VI; 2006 (Dissertation, in French).
5. Boulet B, Bouvier-Capely C, Cossonnet C, Cote G. Solvent extraction of U(VI) by calix[6]arenes. Solvent Extraction Ion Exchange 24:319 -330; 2006.
6. Bouvier-Capely C, Baglan N, Montegue A, Ritt J, Cossonnet C. Validation of uranium determination in urine by ICPMS. Health Phys 85:216-219; 2003.
7. Bouvier-Capely C, Ritt J, Baglan N, Cossonnet C. Potentialities of mass spectrometry (ICP-MS) for actinides determination in urine. Applied Radiat Isotopes 60:629-633; 2004.
8. De Rey BM, Lanfranchi HE, Cabrini RL. Percutaneous absorption of uranium compounds. Environmental Res 30:480- 491; 1983.
9. Durbin PW, Lauriston S. Taylor Lecture: The quest for therapeutic actinide chelators. Health Phys 95:465-492; 2008.
10. Duval R, Cossonnet C, Bouvier-Capely C, Le Strat C, Boulet B. Chelator. Fontenay-aux-Roses, France: Institut de Radioprotection et de Sureté Nucléaire, French Patent, FR 2006/ 001105; 2006.
11. Gerber GB, Thomas RG. Internal radionuclide contamination guidebook. Radiat Protect Dosim 41:1- 49; 1992.
12. Houpert P, Chazel V, Paquet F. A local approach to reduce industrial uranium wound contamination in rats. Can J Physiol Pharmacol 82:73-78; 2004.
13. Lopez R, Diaz Sylvester PL, Ubios AM, Cabrini RL. Percutaneous toxicity of uranyl nitrate: its effect in terms of exposure area and time. Health Phys 78:434-437; 2000.
14. Petitot F, Moreels AM, Paquet F. In vitro evaluation of percutaneous diffusion of uranyl nitrate through intact or excoriated skin of rat and pig. Can J Physiol Pharmacol 82:133-139; 2004.
15. Petitot F, Frelon S, Moreels AM, Claraz M, Delissen O, Tourlonias E, Dhieux B, Maubert C, Paquet F. Incorporation and distribution of uranium in rats after a contamination on intact or wounded skin. Health Phys 92:464-474; 2007a.
16. Petitot F, Gautier C, Moreels AM, Frelon S, Paquet F. Percutaneous penetration of uranium in rats after a contamination on intact or wounded skin. Radiat Protect Dosim 127:125-130; 2007b.
17. Spagnul A, Bouvier-Capely C, Phan G, Rebière F, Fattal E. Design of a calixarene-entrapped nanoemulsion for the extraction of uranium in biological media. J Pharm Sci 99:1375-1383; 2010.
18. Xu K, Ge W, Liang G, Wang L, Yang Z, Wang Q, Hsing IM, Xu B. Bisphosphonate-containing supramolecular hydrogels for topical decorporation of uranium-contaminated wounds in mice. International J Radiat Biol 84:353-362; 2008.
19. Yang Z, Xu K, Wang L, Gu H, Wei H, Zhang M, Xu B. Self-assembly of small molecules affords multifunctional supramolecular hydrogels for topically treating simulated uranium wounds. Chemical Communications 4414-4416; 2005.